Terbinafine
Product Images NDC 71335-1668

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 71335-1668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351668)

Terbinafine 250mg tablet packaging label from Bryant Ranch Prepack. The label includes comparison to Lamisil 250mg tablets by InvaGen Pharmaceuticals Inc. It indicates a quantity of 30 tablets and provides storage instructions at room temperature 20°-25°C (68°-77°F). The label also includes a lot number 1523487 and a barcode, along with a caution to keep all drugs out of reach of children. The product NDC is 71335-1668-1.*

FDA Label Image

Image 2 (Terbinafine Str)

Chemical structure of Terbinafine hydrochloride showing its molecular framework with aromatic rings, a tertiary amine, and an isoprenyl side chain.*

FDA Label Image

Image 1 (Terbinafine Table)

A data table summarizing adverse events and discontinuation rates for Terbinafine tablets versus placebo. It presents percentages of patients experiencing headaches, gastrointestinal symptoms, dermatological symptoms, liver enzyme abnormalities, taste disturbances, and visual disturbances during treatment and at discontinuation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.